Radiotherapy for Primary Urethral Carcinoma (PUC): An Illustrative and Narrative Review
Shreya Dhingra1, Arunima Nagar1, Amandeep Arora2
1Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
None:
Primary urethral carcinoma (PUC) is a rare malignancy with a complex and site-specific management paradigm. While surgery remains the mainstay for many cases, advances in modern radiotherapy have facilitated organ preservation without compromising oncologic outcomes. This narrative review outlines the clinicopathological features, diagnostic evaluation, and evolving role of radiotherapy in the management of PUC. An illustrative case of a young male with high-grade urothelial carcinoma of the bulbar urethra managed successfully with definitive external beam radiotherapy is presented. We explore the rationale, technique, and outcomes associated with radiotherapy, including external beam and brachytherapy modalities, across disease stages. For locally advanced cases, chemoradiotherapy offers an organ-sparing alternative to mutilating surgery, with promising control rates and acceptable toxicity. This article aims to collate current evidence, highlight gaps, and support the integration of personalised, multidisciplinary care in this rare disease context.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Related Concept Videos
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
